H & B Pharmaceutica LLP
About H & B Pharmaceutica LLP
Data last updated:
H & B Pharmaceutica LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 July 2014 and has been in existence for over 12 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAC-5064.
The LLP has a total obligation of contribution of ₹10 Lakh. It is led by designated partners Hemanth Balakrishna Hegde and Anaita Udwadia Hegde.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 607 Om Chambers 123 August Kranti Marg Kemps Corner, Mumbai, Maharashtra, India – 400036.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹14.53 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹1.19 Cr (net margin 8.2%) and EBITDA of ₹1.73 Cr (EBITDA margin 11.9%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 15% over five years.
Company details
Contact details
H & B Pharmaceutica LLP's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address607 Om Chambers 123 August Kranti Marg Kemps Corner, Mumbai, Maharashtra, India – 400036
- IndustryPharma, Drug Formulation & Development
To see the full contact details of H & B Pharmaceutica LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of H & B Pharmaceutica LLP
FY 2025 filings availableH & B Pharmaceutica LLP reported revenue of ₹14.53 Cr (up 33% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 33% growth in the latest year. EBITDA rose 297% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹1.19 Cr | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 8.2% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of H & B Pharmaceutica LLP, buy the company report.
Designated partners of H & B Pharmaceutica LLP
H & B Pharmaceutica has 2 current designated partners and 4 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemanth Balakrishna Hegde Also directs: Heba Pharmaceutica LLP, Hegde & Hegde Pharmaceutica LLP, H and H Pharmaceutica Private Limited and 1 more | Designated Partner | 25 Jul 2014 | 12 Years 3 Months | Current |
| Anaita Udwadia Hegde Also directs: Heba Pharmaceutica LLP, Hegde & Hegde Pharmaceutica LLP, H and H Pharmaceutica Private Limited and 2 more | Designated Partner | 01 Feb 2017 | 9 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving H & B Pharmaceutica LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for H & B Pharmaceutica LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for H & B Pharmaceutica LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
H & B Pharmaceutica LLP has 6 designated partner changes on record since 2014: 4 appointments and 2 cessations. The latest: Balakrishna Vorvady Hegde ceased to be Designated Partner on 09 Nov 2020.
Frequently asked questions
H & B Pharmaceutica is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 25 July 2014 (12+ years old) and is registered under LLPIN AAC-5064.
H & B Pharmaceutica has 2 current designated partners:
- Hemanth Balakrishna Hegde - Designated Partner
- Anaita Udwadia Hegde - Designated Partner
The latest financial statements of H & B Pharmaceutica on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from 2015 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of H & B Pharmaceutica is AAC-5064. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
H & B Pharmaceutica was incorporated on 25 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
Balakrishna Vorvady Hegde ceased to be Designated Partner on 09 Nov 2020. Anaita Udwadia Hegde was appointed as Designated Partner on 01 Feb 2017. Rohaan Hemanth Hegde was appointed as Partner on 01 Feb 2017. H & B Pharmaceutica has 6 designated partner changes on record in total.
The registered office of H & B Pharmaceutica is at 607 Om Chambers 123 August Kranti Marg Kemps Corner, Mumbai, Maharashtra, India – 400036.
H & B Pharmaceutica operates in the pharma industry, in the drug formulation and development segment.
H & B Pharmaceutica can be reached at its registered office: 607 Om Chambers 123 August Kranti Marg Kemps Corner, Mumbai, Maharashtra, India – 400036.
H & B Pharmaceutica is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.